Technology area: Chemistry & Materials
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Stavro Medical Inc. currently has 1 pending office actions within the Chemistry & Materials technology area. This action is being processed in 1 distinct art units, which shows a focused technical direction for the company's filings. The prosecution involves 1 distinct examiners, concentrating the company's legal efforts on this individual. This arrangement means that the company does not have to manage multiple examiner relationships or different standards simultaneously.
The busiest examiner assigned to this portfolio is MCDERMOTT, JEANNIE, who holds 1 busiest examiner pending office action. Because the total number of 1 pending office actions is limited, this examiner is responsible for all active prosecution for the company. Practitioners should observe that with 1 distinct examiners and 1 distinct art units, the prosecution strategy is streamlined. The success of the Chemistry & Materials portfolio currently hinges on the resolution of the applications through this individual. This approach allows for a direct response to the examiner's specific concerns.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Double-patenting + other | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| MCDERMOTT, JEANNIE | 1 | 60.4% | +15.1% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18197907 | SINGLE LUMEN HYBRID CONNECTION TO LEGACY SYSTEM | MCDERMOTT, JEANNIE | — |
| Art Unit | Apps |
|---|---|
| 1777 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18197907 | SINGLE LUMEN HYBRID CONNECTION TO LEGACY SYSTEM | MCDERMOTT, JEANNIE | 1777 | §102§103DP | Non-Final OA | — | Pending | May 16, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialStavro Medical Inc. has 1 pending office actions as of October 2026, spread across 1 art units and 1 examiners.
Jeannie Mcdermott has the most, with 1 of Stavro Medical Inc.'s pending office actions.
Mostly Chemistry & Materials (USPTO Tech Center 1700), based on where its pending office actions are examined.
